Posted by Michael Wonder on 22 Mar 2022
Prescription medicines: applications under evaluation (March 2022)
22 March 2022 - The TGA has updated its list of applications for new medicines or new uses for existing medicines that are currently under evaluation.
Only two new applications were accepted for evaluation in February:
- Icosapent ethyl (Vazkepa) - new medicine
- Upadacitinib monohydrate (Rinvoq) - new indication
